If Merk had the kimd of clinical data that regulatory authorities want for approval, they would have submitted. They wouldn’t hold back data and lose money. The clinical data wasn’t there when it was approved for women. It came later. Studies take years and millions of dollars. They wouldn’t hide this info and then…